FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Rifampin Capsule
Status: Currently in Shortage
»Date first posted: 12/22/2021
»Therapeutic Categories: Anti-Infective

Expand all

Epic Pharma, LLC (Reverified 02/04/2026)

Company Contact Information:
(718) 276-8600 ext. 3

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Rifampin, Capsule, 150 mg (NDC 42806-801-30)	Available
Rifampin, Capsule, 150 mg (NDC 42806-801-01)	Unavailable	Discontinuation of the manufacture of the drug.	Discontinuation of the manufacture of the drug
Rifampin, Capsule, 300 mg (NDC 42806-799-30)	Unavailable	Discontinuation of the manufacture of the drug.	Discontinuation of the manufacture of the drug
Rifampin, Capsule, 300 mg (NDC 42806-799-60)	Available
Rifampin, Capsule, 300 mg (NDC 42806-799-01)	Unavailable	Discontinuation of the manufacture of the drug.	Discontinuation of the manufacture of the drug
Rifampin, Capsule, 300 mg (NDC 42806-799-05)	Unavailable	Discontinuation of the manufacture of the drug.	Discontinuation of the manufacture of the drug

Lupin Pharmaceuticals, Inc. (Revised 01/08/2026)

Company Contact Information:
866-587-4617

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Rifampin, Capsule, 150 mg (NDC 68180-658-06)	Limited Availability	On allocation	Shortage of an active ingredient
Rifampin, Capsule, 300 mg (NDC 68180-659-06)	Limited Availability	On allocation	Shortage of an active ingredient
Rifampin, Capsule, 300 mg (NDC 68180-659-07)	Limited Availability	On allocation	Shortage of an active ingredient